Current Price
Open
Previous Close
Day High
Day Low
Last updated:
About
Microbix Biosystems Inc. is a Canadian diagnostic company specializing in the development, manufacture, and commercialization of biological products for the global diagnostics and life sciences industries. The company primarily produces high-quality antigens and control materials used in clinical testing, focusing on infectious disease diagnostics and quality assurance programs worldwide. Microbix is dedicated to supporting reliable testing through its proprietary technologies and manufacturing processes.
Latest MFT Stock News
Loading latest news...
Consensus EPS estimates fall by 12%
Analysts have decreased their earnings per share (EPS) estimates for Mainfreight, indicating a potentially less profitable future.
Consensus revenue estimates increase by 11%
Despite lowered EPS estimates, analysts project an increase in Mainfreight's revenue, suggesting stronger sales performance.
Upcoming dividend of NZ$1.00 per share
Mainfreight is set to distribute a dividend of NZ$1.00 per share, returning value to its shareholders.
First half 2026 earnings released: EPS: NZ$0.93 (vs NZ$1.14 in 1H 2025)
Mainfreight's first-half earnings for 2026 show a decrease in EPS compared to the same period in 2025, indicating a potential decline in profitability.
Mainfreight Full Year 2025 Earnings: EPS: NZ$2.72 (vs NZ$2.07 in FY 2024)
Mainfreight's full year earnings for 2025 show an increase in EPS compared to the same period in 2024, indicating an increase in profitability.
AI Analysis
No news available for this stock